Table 2 Primary and secondary study clinical outcomes up to day 28
From: Efficacy of different doses of corticosteroids in treating severe COVID-19 pneumonia
Variable | Ventilator-free days, mean ± SD | 28-day mortality, n (%) | Days of temperature return to normal mean ± SD | Number of fungal infection n (%) |
|---|---|---|---|---|
High-dose group | 12.19 ± 1.30 | 1(4.76%) | 2.00 ± 0.46 | 8(38.1%) |
Low-dose group | 13.92 ± 1.40 | 3(11.11%) | 4.48 ± 1.04 | 8(29.6%) |
t/ × 2 | 0.885 | 0.623 | 1.974 | 0.381 |
P-value | 0.38 | 0.43 | 0.04 | 0.53 |